Olema Pharmaceuticals, Inc. OLMA Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s change in other liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported change in other liabilities of $1.3M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s change in other liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s change in other liabilities increased by 111.6% year-over-year, from -$11.25M to $1.3M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s change in other liabilities?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s change in other liabilities has grown at a 16.1% compound annual growth rate (CAGR), from $7.02M to $10.98M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.